Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Re Agreement

13 Aug 2007 07:00

Embargoed Release: 07:00hrs Monday 13 August 2007

SOPHEON PLC ("Sopheon") SOPHEON NAMED TO ENABLE TRANSITION OF IDe CUSTOMERS Arrangement Extends Sopheon's Position as Industry's Leading Provider of Product Roadmapping, Planning and Process Automation Solutions

Sopheon plc announces today that its affiliate, Sopheon Corporation, has entered into an agreement with Integrated Development Enterprise, Inc. ("IDe") under which Sopheon intends to offer transition services and support to IDe customers previously covered by IDe maintenance and support contracts. The agreement follows a recent decision by IDe to discontinue its business.

Founded in 1998, Boston-based IDe specialized in providing product portfolio management software solutions to large manufacturers and services companies. IDe has announced Sopheon, a former competitor, to its customers as an alternate source of services and assistance that IDe will no longer be able to provide.

Terms of the agreement afford Sopheon exclusive access to such IDe assets as its customer list, software code and all documentation relating to IDe's software. Sopheon intends to contact each of IDe's customers to discuss potential support options, including transitioning to Sopheon's Accolade‚® software and services. However, Sopheon is not committed to assume, nor is it legally bound to, any of IDe's obligations to IDe's former end-users, and terms and conditions of the transition will be as agreed between Sopheon and IDe's individual customers. IDe's client base of 18 companies is approximately one-fifth the size of Sopheon's and similarly includes many Fortune 1000 companies.

Sopheon's outreach to IDe customers began last week. Sopheon said that it views the initiative as a unique opportunity to expand its customer population while also increasing maintenance and support revenue.

Less than 60 days ago, Sopheon was successful in a bid to acquire the assets of Alignent Software, a California-based supplier of advanced product and technology roadmapping solutions. The consolidation of Alignent enabled Sopheon to extend its product life cycle management solution footprint to include product planning. Sopheon believes that the agreement with IDe will build on Sopheon's history of steady, substantial growth in the expanding product portfolio and innovation process management market. Since Sopheon's launch of its Accolade solution six years ago, its Accolade-related revenues in dollar terms have increased at an average rate of nearly 50% per year.

Barry Mence, chairman of Sopheon, commented:

"There is good compatibility between IDe's flagship offering and Sopheon's Accolade. There is also a strong fit between our client bases. Add to this the fact that we already know a fair amount about IDe's application, and we believe we are in a position to offer a seamless transition to IDe customers."

For further information contact:

Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO David Newton Seymour Pierce Limited Tel: +44 (0) 207 107 8000 Jonathan Wright, Nominated Advisers Andrew Tan Hansard Group Tel : + 44 (0) 207 245 1100 + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010 About Sopheon

Sopheon is an international provider of software and services that help organizations improve the business impact of product innovation. Sopheon's Accolade system automates and governs the innovation process, enabling companies to increase revenue and profits from new products. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com.

SOPHEON PLC
Date   Source Headline
6th Dec 20137:00 amRNSDirector/PDMR Shareholding
5th Dec 20137:00 amRNSCorporate Update
19th Nov 20137:00 amRNSSopheon Delivers Accolade® Release 9.0
7th Nov 20137:00 amRNSInterim Management Statement
11th Sep 20133:00 pmRNSHolding(s) in Company
4th Sep 20133:00 pmRNSHolding(s) in Company
22nd Aug 20137:00 amRNSInterim Results
15th Aug 20133:00 pmRNSHolding(s) in Company
29th Jul 20133:00 pmRNSHolding(s) in Company
26th Jul 20137:00 amRNSTrading Update
15th Jul 20134:15 pmRNSHolding(s) in Company
28th Jun 20133:00 pmRNSTotal Voting Rights
27th Jun 20133:00 pmRNSHolding(s) in Company
19th Jun 20133:42 pmRNSHolding(s) in Company
19th Jun 20137:00 amRNSNew capabilities with Accolade(R) 8.3
14th Jun 20132:00 pmRNSContract Win
12th Jun 201312:00 pmRNSResult of AGM & GM
12th Jun 20137:00 amRNSAGM Statement
4th Jun 20137:00 amRNSIssue of Shares
2nd May 20137:00 amRNSInterim Management Statement
21st Mar 20137:00 amRNSPreliminary Results
30th Jan 20137:00 amRNSTrading Update
23rd Jan 20137:00 amRNSLaunch of Accolade 8.2
7th Dec 201211:36 amPRNHolding(s) in Company
8th Nov 20127:00 amPRNInterim Management Statement
1st Oct 20127:00 amRNSHolding(s) in Company
1st Oct 20127:00 amRNSDirectors' Options
24th Sep 20127:00 amRNSMarket Transfer to NYSE Alternext Concluded
23rd Aug 20127:00 amRNSAmendment to Terms of Convertible Loan Stock
23rd Aug 20127:00 amRNSInterim Results
23rd Jul 20127:00 amRNSTrading Update
13th Jun 20123:14 pmRNSResult of AGM
13th Jun 20127:00 amRNSAGM Statement
15th May 20127:00 amRNSAmendment to terms of Convertible Loan Stock
3rd May 20127:00 amRNSInterim Management Statement
25th Apr 20127:00 amRNSLaunch of Accolade 8.0
22nd Mar 20127:00 amRNSPreliminary Results
16th Feb 20127:00 amRNSTop 10 Solution Provider to CGM
31st Jan 20127:00 amRNSTrading Update
23rd Dec 201112:32 pmRNSExtension of GEM Equity Line
23rd Dec 201112:29 pmRNSTrading Update
5th Dec 201112:40 pmRNSHolding(s) in Company
3rd Nov 20117:00 amRNSInterim Management Statement
25th Aug 20117:00 amRNSInterim Results
25th Jul 20117:00 amRNSTrading Statement
23rd Jun 20112:15 pmRNSDirector/PDMR Shareholding
15th Jun 20117:00 amRNSAGM Statement
5th May 20117:00 amRNSInterim Management Statement
24th Mar 20117:00 amRNSPreliminary Results
10th Feb 20117:00 amPRNAppointment of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.